Magle Chemoswed Holding Past Earnings Performance
Past criteria checks 5/6
Magle Chemoswed Holding has been growing earnings at an average annual rate of 28.5%, while the Life Sciences industry saw earnings growing at 28.5% annually. Revenues have been growing at an average rate of 7.2% per year. Magle Chemoswed Holding's return on equity is 3.4%, and it has net margins of 8%.
Key information
28.5%
Earnings growth rate
22.7%
EPS growth rate
| Life Sciences Industry Growth | 31.8% |
| Revenue growth rate | 7.2% |
| Return on equity | 3.4% |
| Net Margin | 8.0% |
| Next Earnings Update | 26 Feb 2025 |
Recent past performance updates
Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Weaker Than They Seem
Nov 04
Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality
Apr 26Recent updates
Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Weaker Than They Seem
Nov 04Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher
Jun 26Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet
Jun 19Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality
Apr 26Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%
Mar 29Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings
Oct 05Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?
Jan 22Revenue & Expenses Breakdown
How Magle Chemoswed Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 209 | 17 | 155 | 0 |
| 30 Jun 24 | 179 | 8 | 138 | 0 |
| 31 Mar 24 | 171 | 12 | 132 | 0 |
| 31 Dec 23 | 171 | 12 | 131 | 0 |
| 30 Sep 23 | 160 | 8 | 124 | 0 |
| 30 Jun 23 | 158 | 9 | 121 | 0 |
| 31 Mar 23 | 155 | 8 | 120 | 0 |
| 31 Dec 22 | 148 | 9 | 113 | 0 |
| 30 Sep 22 | 138 | 10 | 106 | 0 |
| 30 Jun 22 | 136 | 10 | 108 | 0 |
| 31 Mar 22 | 133 | 7 | 106 | 0 |
| 31 Dec 21 | 132 | 4 | 106 | 0 |
| 30 Sep 21 | 137 | 3 | 105 | 0 |
| 30 Jun 21 | 133 | 1 | 99 | 0 |
| 31 Mar 21 | 134 | 2 | 99 | 0 |
| 31 Dec 20 | 142 | 2 | 100 | 0 |
| 30 Sep 20 | 151 | 14 | 103 | 0 |
| 30 Jun 20 | 140 | 8 | 104 | 0 |
| 31 Mar 20 | 137 | 1 | 100 | 0 |
| 31 Dec 19 | 132 | 1 | 96 | 0 |
| 31 Dec 18 | 110 | -3 | 99 | 0 |
Quality Earnings: MAGLE has high quality earnings.
Growing Profit Margin: MAGLE's current net profit margins (8%) are higher than last year (5.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MAGLE has become profitable over the past 5 years, growing earnings by 28.5% per year.
Accelerating Growth: MAGLE's earnings growth over the past year (104.1%) exceeds its 5-year average (28.5% per year).
Earnings vs Industry: MAGLE earnings growth over the past year (104.1%) exceeded the Life Sciences industry 36%.
Return on Equity
High ROE: MAGLE's Return on Equity (3.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 03:38 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Magle Chemoswed Holding AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kevin Sule | Redeye |